Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation

Kidney and Blood Pressure Research

Volumn 30, Issue 6, 2007, Pages 421-429

  Waeckerle Men, Ying ^a   Starke, Astrid ^a   Wahl, Patricia R ^a   Wüthrich, Rudolf P ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Costimulatory molecules; Inflammatory cytokine; PD L1; Renal proximal tubular epithelial cell; T cell activation

Indexed keywords

BETA INTERFERON; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INDUCIBLE COSTIMULATORY MOLECULE LIGAND; INTERFERON; OVALBUMIN; PROGRAMMED DEATH 1 LIGAND 1 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; IMMUNE RESPONSE; INFLAMMATION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; EPITHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERFERON-BETA; KIDNEY TUBULES, PROXIMAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; PROTEINS; T-LYMPHOCYTES;

EID: 36549033266     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110578     Document Type: Article

References (30)

1. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 1991;2:13-26.
2. Meyers CM: New insights into the pathogenesis of interstitial nephritis. Curr Opin Nephrol Hypertens 1999;8:287-292.
3. van Kooten C, Daha MR, van Es LA: Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 1999;7:429-437.
4. Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005;23:515-548.
5. Watts TH: TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
6. Chen L: Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-347.
7. Keir ME, Sharpe AH: The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 2005;204:128-143.
8. Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wuthrich RP: Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant 2004;19:2713-2720.
9. Wahl P, Wuthrich RP: Role of the B7RP-1/ICOS pathway in renal tubular epithelial antigen presentation to CD4 Th1 and Th2 cells. Nephron Exp Nephrol 2004;98:e31-e38.
10. de Haij S, Woltman AM, Trouw LA, Bakker AC, Kamerling SW, van der Kooij SW, Chen L, Kroczek RA, Daha MR, van Kooten C: Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1. Kidney Int 2005;68:2091-2102.
11. Chen Y, Zhang J, Li J, Zou L, Zhao T, Tang Y, Wu Y: Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron Exp Nephrol 2006;102:e81-e92.
12. Waeckerle-Men Y, Starke A, Wuthrich RP: PD-L1 partially protects renal tubular epithelial cells from the attack of CD8 cytotoxic T cells. Nephrol Dial Transplant 2007;22:1527-1536.
13. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR: T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
14. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990;37:783-792.
15. Waeckerle-Men Y, Gander B, Groettrup M: Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med 2005;109:35-46.
16. Singer GG, Yokoyama H, Bloom RD, Jevnikar AM, Nabavi N, Kelley VR: Stimulated renal tubular epithelial cells induce anergy in CD4 T cells. Kidney Int 1993;44:1030-1035.
17. Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G, Lechler R: Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int 1998;53:679-689.
18. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, Zinkernagel RM: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005;11:138-145.
19. Hagerty DT, Evavold BD, Allen PM: Regulation of the costimulator B7, not class II major histocompatibility complex, restricts the ability of murine kidney tubule cells to stimulate CD4 T cells. J Clin Invest 1994;93:1208-1215.
20. Wahl P, Schoop R, Bilic G, Neuweiler J, Le Hir M, Yoshinaga SK, Wuthrich RP: Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 2002;13:1517-1526.
21. Blank C, Gajewski TF, Mackensen A: Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother 2005;54:307-314.
22. Rini BI: Current status and future directions of molecular markers in renal cell carcinoma. Curr Opin Urol 2006;16:332-336.
23. Dong H, Chen X: Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol Immunol 2006;3:179-187.
24. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH: Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006;203:2223-2227.
25. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED: Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 2006;66:3381-3385.
26. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-151.
27. Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH: PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci USA 2004;101:10691-10696.
28. Koga N, Suzuki J, Kosuge H, Haraguchi G, Onai Y, Futamatsu H, Maejima Y, Gotoh R, Saiki H, Tsushima F, Azuma M, Isobe M: Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler Thromb Vasc Biol 2004;24:2057-2062.
29. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, Najafian N, Yagita H, Azuma M, Turka LA, Sayegh MH: Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 2005;174:3408-3415.
30. Gao W, Demirci G, Strom TB, Li XC: Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 2003;76:994-999.